ALK and lung cancer: A recent study showed that massive enhancer remodeling plays a key role in acquired resistance to anaplastic lymphoma kinase (ALK) inhibitors and that panobinostat can induce chromatin remodeling in resistant cells to overcome acquired resistance to ALK inhibitors in ALK-positive lung cancer [40].